Interagency Patent Coordination and Improvement Act of 2023
Latest action · Mar 1, 2023 Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 25, 2023
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Interagency Patent Coordination and Improvement Act of 2023
This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.
The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the PTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the PTO, and (3) the PTO to assist the FDA in its ministerial role of listing patents.
Cosponsors 5
Members who signed on, in the order they did. Signatures ran from Jan 25, 2023 to Feb 7, 2023; 3 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-DE | Christopher A. Coons | Original | Jan 25, 2023 |
| R-IA | Chuck Grassley | Original | Jan 25, 2023 |
| R-NC | Thom Tillis | Original | Jan 25, 2023 |
| D-CA | Dianne Feinstein | Feb 7, 2023 | |
| D-VT | Peter Welch | Feb 7, 2023 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Judiciary Committee | Referred Jan 25, 2023Markup Feb 9, 2023Reported Mar 1, 2023 |
Actions 5
Everything that happened, newest first.
- Mar 1, 2023Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
- Mar 1, 2023Placed on Senate Legislative Calendar under General Orders. Calendar No. 18.
- Feb 9, 2023Committee on the Judiciary. Ordered to be reported without amendment favorably.
- Jan 25, 2023Introduced in Senate
- Jan 25, 2023Read twice and referred to the Committee on the Judiciary.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Text printed S102 | Richard J. Durbin D-IL (text) | Jan 25, 2023 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Congressional Budget Office cost estimate
- Jul 6, 2023S. 79, Interagency Patent Coordination and Improvement Act of 2023As reported by the Senate Committee on the Judiciary on March 1, 2023
Printed hearings 2
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 118-442 | HEALTH CARE TRANSPARENCY: LOWERING COSTS AND EMPOWERING PATIENTS94 pages | Aging (Special) Committee | Jul 11, 2024 |
| S. Hrg. 118-542 | PHARMACY BENEFIT MANAGERS AND THE PRESCRIPTION DRUG SUPPLY CHAIN: IMPACT ON PATIENTS AND TAXPAYERS280 pages | Finance Committee | Mar 30, 2023 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R47373 | Science and Technology Issues for the 118th Congress Archived | Report | Oct 15, 2024 |
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 1717 | Interagency Patent Coordination and Improvement Act of 2023 | Identical bill | Mar 22, 2023 |
| HR 4570 | Interagency Patent Coordination and Improvement Act of 2025 | Cross-Congress related bill | Jul 21, 2025 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
- Short Title(s) as Introduced
- Interagency Patent Coordination and Improvement Act of 2023
- Short Title(s) as Reported to Senate
- Interagency Patent Coordination and Improvement Act of 2023
Subjects
Assigned by the Library of Congress. Policy area: Commerce.
Text 2
Each version as it was printed, newest first.
- Mar 1, 2023Reported to Senate
- Jan 25, 2023Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.